TY - JOUR
T1 - Insights into host-pathogen interactions from state-of-the-art animal models of respiratory Pseudomonas aeruginosa infections
AU - Lorenz, Anne
AU - Pawar, Vinay
AU - Häussler, Susanne
AU - Weiss, Siegfried
N1 - © 2016 Federation of European Biochemical Societies.
PY - 2016/11
Y1 - 2016/11
N2 - Pseudomonas aeruginosa is an important opportunistic pathogen that can cause acute respiratory infections in immunocompetent patients or chronic infections in immunocompromised individuals and in patients with cystic fibrosis. When acquiring the chronic infection state, bacteria are encapsulated within biofilm structures enabling them to withstand diverse environmental assaults, including immune reactions and antimicrobial therapy. Understanding the molecular interactions within the bacteria, as well as with the host or other bacteria, is essential for developing innovative treatment strategies. Such knowledge might be accumulated in vitro. However, it is ultimately necessary to confirm these findings in vivo. In the present Review, we describe state-of-the-art in vivo models that allow studying P. aeruginosa infections in molecular detail. The portrayed mammalian models exclusively focus on respiratory infections. The data obtained by alternative animal models which lack lung tissue, often provide molecular insights that are easily transferable to mammals. Importantly, these surrogate in vivo systems reveal complex molecular interactions of P. aeruginosa with the host. Herein, we also provide a critical assessment of the advantages and disadvantages of such models.
AB - Pseudomonas aeruginosa is an important opportunistic pathogen that can cause acute respiratory infections in immunocompetent patients or chronic infections in immunocompromised individuals and in patients with cystic fibrosis. When acquiring the chronic infection state, bacteria are encapsulated within biofilm structures enabling them to withstand diverse environmental assaults, including immune reactions and antimicrobial therapy. Understanding the molecular interactions within the bacteria, as well as with the host or other bacteria, is essential for developing innovative treatment strategies. Such knowledge might be accumulated in vitro. However, it is ultimately necessary to confirm these findings in vivo. In the present Review, we describe state-of-the-art in vivo models that allow studying P. aeruginosa infections in molecular detail. The portrayed mammalian models exclusively focus on respiratory infections. The data obtained by alternative animal models which lack lung tissue, often provide molecular insights that are easily transferable to mammals. Importantly, these surrogate in vivo systems reveal complex molecular interactions of P. aeruginosa with the host. Herein, we also provide a critical assessment of the advantages and disadvantages of such models.
KW - Animals
KW - Anti-Infective Agents/therapeutic use
KW - Bacterial Proteins/metabolism
KW - Biofilms
KW - Disease Models, Animal
KW - Host-Pathogen Interactions
KW - Humans
KW - Pseudomonas Infections/drug therapy
KW - Pseudomonas aeruginosa/physiology
KW - Respiratory Tract Infections/metabolism
U2 - 10.1002/1873-3468.12454
DO - 10.1002/1873-3468.12454
M3 - Review
C2 - 27730639
SN - 0014-5793
VL - 590
SP - 3941
EP - 3959
JO - FEBS Letters
JF - FEBS Letters
IS - 21
ER -